Should we be worried about pharma’s supply chain?
World of DTC Marketing
APRIL 12, 2021
We can’t continue to develop drugs the same way as we have done before. A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. The question that I kept asking was why?
Let's personalize your content